Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06913023 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus

Study acronym: SPOT-DM
StatusNot Yet Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 7 months later Nov 30, 2027 → Jun 30, 2029
Enrollment reduced 50% 74 → 37 participants
See other at-risk trials from University Health Network, Toronto

Record History

  1. Primary completion pushed from Nov 30, 2027 to Jun 30, 2029 Enrollment reduced: 74 → 37 participants · Start date: Jan 5, 2026 to Sep 5, 2026 · Completion pushed from Nov 30, 2027 to Dec 30, 2029 · 6 more Show 9 more changesShow less
    • Enrollment reduced: 74 → 37 participants
    • Start date: Jan 5, 2026 to Sep 5, 2026
    • Completion pushed from Nov 30, 2027 to Dec 30, 2029
    • Interventions modified
    • Trial arms changed: 2 → 1
    • Eligibility criteria expanded, about 21 words
    • Secondary endpoints: 20 to 19
    • Study description shortened, about 6 words
    • Site details revised at 2 of 2 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to determine the short-term efficacy, mechanisms and safety of 24 weeks of semaglutide therapy in 37 KTR at risk of post-transplant diabetes mellitus (PTDM).
Trial Details
NCT Number NCT06913023
Lead Sponsor University Health Network, Toronto
Conditions Kidney Transplant Recipient
Enrollment 37 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov